Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1517/17425240802431811 PMID 18976129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heparin-conjugated star-shaped PLA for improved biocompatibility.

  2008cited by this paper
• Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle.

  2008cited by this paper
• Heparin/poly(l-lysine) nanoparticle-coated polymeric microspheres for stem-cell therapy.

  2007cited by this paper
• Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate.

  2007cited by this paper
• Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor.

  2007cited by this paper
• Thermally reversible pluronic/heparin nanocapsules exhibiting 1000-fold volume transition.

  2006cited by this paper
• Heparin binding nanostructures to promote growth of blood vessels.

  2006cited by this paper
• Nerve guidance channels as drug delivery vehicles.

  2006cited by this paper
• A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.

  2006cited by this paper
• Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.

  2006cited by this paper
• Inductive tissue engineering with protein and DNA-releasing scaffolds.

  2006cited by this paper
• Novel, fluorescent, magnetic, polysaccharide-based microsphere for orientation, tracing, and anticoagulation: preparation and characterization.

  2005cited by this paper
• In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.

  2005cited by this paper
• Pharmacologically active microcarriers: a tool for cell therapy.

  2005cited by this paper
• Mechanisms underlying differential responses to FGF signaling.

  2005cited by this paper
• Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)

  2005cited by this paper
• Effect of basic fibroblast growth factor incorporating gelatin microspheres on erectile function in the diabetic rat.

  2005cited by this paper
• PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

  2005cited by this paper
• Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.

  2005cited by this paper
• VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.

  2004cited by this paper
• Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells.

  2004cited by this paper
• Heparin conjugated polylactide as a blood compatible material.

  2004cited by this paper
• In vitro release of vascular endothelial growth factor from gadolinium‐doped biodegradable microspheres

  2004cited by this paper
• Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation

  2004cited by this paper
• Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release.

  2003cited by this paper
• Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits.

  2003cited by this paper
• Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits.

  2003cited by this paper
• Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion.

  2003cited by this paper
• Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.

  2003cited by this paper
• Protein-based signaling systems in tissue engineering.

  2003cited by this paper
• Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.

  2003cited by this paper
• Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats

  2003cited by this paper
• Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.

  2002cited by this paper
• Effect of mammalian cell culture medium on the gelation properties of Pluronic F127.

  2002cited by this paper
• Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.

  2002cited by this paper
• Heparin-protein interactions.

  2002cited by this paper
• Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.

  2002cited by this paper
• Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing

  2002cited by this paper
• Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis.

  2002cited by this paper
• A new nerve guide conduit material composed of a biodegradable poly(phosphoester).

  2001cited by this paper
• A novel formulation for controlled release of heparin-DOCA conjugate dispersed as nanoparticles in polyurethane film.

  2001cited by this paper
• Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

  2001cited by this paper
• Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis.

  2001cited by this paper
• Combination of Growth Factors Inhibits Bone Ingrowth in the Bone Harvest Chamber

  2001cited by this paper
• Polymeric system for dual growth factor delivery

  2001cited by this paper
• Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy

  2001cited by this paper
• Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates.

  2000cited by this paper
• Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.

  2000cited by this paper
• Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique.

  2000cited by this paper
• VEGF gene delivery to myocardium: deleterious effects of unregulated expression.

  2000cited by this paper
• Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons.

  2000cited by this paper
• Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

  2000cited by this paper
• Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders.

  1999cited by this paper
• Peripheral nerve regeneration and neurotrophic factors

  1999cited by this paper
• Instability, stabilization, and formulation of liquid protein pharmaceuticals.

  1999cited by this paper
• Synthesis of thrombin-inhibiting heparin mimetics without side effects

  1999cited by this paper
• Nerve growth factor enhances peripheral nerve regeneration in non-human primates.

  1999cited by this paper
• Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System

  1999cited by this paper
• Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.

  1998cited by this paper
• Materials for protein delivery in tissue engineering.

  1998cited by this paper
• Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system.

  1998cited by this paper
• Characterization of Heparin and Heparan Sulfate Domains Binding to the Long Splice Variant of Platelet-derived Growth Factor A Chain*

  1997cited by this paper
• Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro.

  1997cited by this paper
• Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles.

  1997cited by this paper
• Epithelial coating techniques in the treatment of interstitial cystitis.

  1997cited by this paper
• Polypeptide growth factors: targeted delivery systems.

  1997cited by this paper
• Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues.

  1996cited by this paper
• Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.

  1996cited by this paper
• Neurogenesis in neonatal rat brain is regulated by peripheral injection of basic fibroblast growth factor (bFGF)

  1996cited by this paper
• Stabilization of nerve growth factor in controlled release polymers and in tissue.

  1996cited by this paper
• Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis

  1995cited by this paper
• Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.

  1994cited by this paper
• Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

  1994cited by this paper
• In vitro effects of brain derived neurotrophic factor released from microspheres.

  1994cited by this paper
• Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.

  1994cited by this paper
• Nature of the interaction of heparin with acidic fibroblast growth factor.

  1993cited by this paper
• Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes.

  1993cited by this paper
• The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

  1992cited by this paper
• Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1.

  1992cited by this paper
• Sustained release of nerve growth factor from biodegradable polymer microspheres.

  1992cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• The Transforming Growth Factor‐Betas: A New Family of Immunoregulatory Molecules

  1990cited by this paper
• Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur

  1990cited by this paper
• Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.

  1990cited by this paper
• Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae.

  1990cited by this paper
• Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment

  1988cited by this paper

• Heparin-Based Growth Factor Delivery Platforms: A Review

  2025cites this paper
• Control and interplay of scaffold-biomolecule interactions applied to cartilage tissue engineering.

  2025cites this paper
• Heparin-Functionalized Bioactive Glass to Harvest Endogenous Growth Factors for Pulp Regeneration.

  2024cites this paper
• Κappa-Carrageenan Modified Polyurethane Foam Scaffolds for Skeletal Muscle Tissue Engineering

  2023cites this paper
• Evaluation of GHK peptide–heparin interactions in multifunctional liposomal covering

  2023cites this paper
• Macro, Micro, and Nano-Inspired Bioactive Polymeric Biomaterials in Therapeutic, and Regenerative Orofacial Applications

  2023cites this paper
• Biocompatibility and Antimicrobial Activity of Electrospun Fibrous Materials Based on PHB and Modified with Hemin

  2023cites this paper
• Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers

  2022cites this paper
• Regeneration of Osteochondral Defects by Combined Delivery of Synovium-Derived Mesenchymal Stem Cells, TGF-β1 and BMP-4 in Heparin-Conjugated Fibrin Hydrogel

  2022cites this paper
• Acellular Vascular Scaffolds Preloaded With Heparin and Hepatocyte Growth Factor for Small-Diameter Vascular Grafts Might Inhibit Intimal Hyperplasia

  2022cites this paper
• The Comparison of Advanced Electrospun Materials Based on Poly(-3-hydroxybutyrate) with Natural and Synthetic Additives

  2022cites this paper
• ECM-mimicking nanofibrous scaffold enriched with dual growth factor carrying nanoparticles for diabetic wound healing

  2021cites this paper
• Effect of the Hemin Molecular Complexes on the Structure and Properties of the Composite Electrospun Materials Based on Poly(3-hydroxybutyrate)

  2021cites this paper
• Bioactive Electrospun Fibers: Fabrication Strategies and a Critical Review of Surface-Sensitive Characterization and Quantification.

  2021cites this paper
• Immobilization of Growth Factors for Cell Therapy Manufacturing

  2020cites this paper
• Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains.

  2020cites this paper
• An injectable heparin-conjugated hyaluronan scaffold for local delivery of Transforming Growth Factor β1 promotes successful chondrogenesis.

  2019cites this paper
• A fully Synthetic Heparan Sulfate-Based Neural Tissue Construct that Maintains the Undifferentiated State of Neural Stem Cells.

  2019cites this paper
• Multiple cargo deliveries of growth factors and antimicrobial peptide using biodegradable nanopolymer as a potential wound healing system

  2019cites this paper
• The Impact of Neuroscience on the Evolution of Decision-Making in Brachial Plexus Surgery. Part II: Nerve Grafts Act as Operator Channels (How the New May Meet the Old)

  2018cites this paper
• Biomaterials for Implants and Scaffolds

  2017cites this paper
• Stimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet‐transplantation enhances immediate post‐transplant islet graft function but not long‐term normoglycemia

  2017cites this paper
• The use of heparin chemistry to improve dental osteogenesis associated with implants.

  2017cites this paper
• RECENT REVIEW ON NANOFIBER FOR DRUG DELIVERY SYSTEMS

  2017cites this paper
• Bioinspired Heparin Nanosponge Prepared by Photo-crosslinking for Controlled Release of Growth Factors

  2017cites this paper
• In vivo efficiency of the collagen coated nanofibrous scaffold and their effect on growth factors and pro‐inflammatory cytokines in wound healing

  2017cites this paper
• Multifunctional Nanocomposite Films for Synergistic Delivery of bFGF and BMP-2

  2017cites this paper
• Characterization of Highly Heterogeneous Heparin-Protein Complexes Using Novel Mass Spectrometry-Based Approaches

  2017cites this paper
• Designer Collagen-Fibril Biograft Materials for Tunable Molecular Delivery

  2016cites this paper
• Tissue engineering advances in spine surgery.

  2016cites this paper
• Poly(3,4-ethylenedioxythiophene):GlycosAminoGlycan Aqueous Dispersions: Toward Electrically Conductive Bioactive Materials for Neural Interfaces.

  2016cites this paper
• Interactions of Intact Unfractionated Heparin with Its Client Proteins Can Be Probed Directly Using Native Electrospray Ionization Mass Spectrometry.

  2016cites this paper
• Hydrogel for Simultaneous Tunable Growth Factor Delivery and Enhanced Viability of Encapsulated Cells in Vitro.

  2016cites this paper
• Growth Factor Gradient Formation and Release from PEG Microspheres for Nerve Regeneration.

  2015cites this paper
• 'Cell or Not to Cell' that is the Question: For Intervertebral Disc Regeneration?

  2015cites this paper
• Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.

  2015cites this paper
• Affinity Release of Insulin-like Growth Factor-1 Increases the Viability of Retinal Pigment Epithelium Cells In Vitro

  2015cites this paper
• Extracellular matrix-inspired BMP-2-delivering biodegradable fibrous particles for bone tissue engineering.

  2015cites this paper
• Biohybrid networks of selectively desulfated glycosaminoglycans for tunable growth factor delivery.

  2014cites this paper
• Drug loading and release from electrospun biodegradable nanofibers.

  2014cites this paper
• The Effects of Heparin Binding Proteins in Platelet Releasate on Bone Formation

  2014cites this paper
• Recent Advances in Nerve Tissue Engineering

  2014cites this paper
• Hydrogels in acellular and cellular strategies for intervertebral disc regeneration

  2013cites this paper
• Signaling pathways regulating dose-dependent dual effects of TNF-α on primary cultured Schwann cells

  2013cites this paper
• Biodegradable micelles from a hyaluronan-poly(ε-caprolactone) graft copolymer as nanocarriers for fibroblast growth factor 1.

  2013cites this paper
• Glycosaminoglycan and chemokine/growth factor interactions.

  2012cites this paper
• Gradient nanofibrous chitosan/poly ɛ-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering.

  2012cites this paper
• Systematic engineering of 3D pluripotent stem cell niches to guide blood development.

  2012cites this paper
• Bone repair: new developments in growth factor delivery systems and their mathematical modeling.

  2012cites this paper
• Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor.

  2012cites this paper
• Heparin - A Century of Progress

  2012cites this paper
• Biomaterial integration within 3D stem cell aggregates for directed differentiation

  2011cites this paper
• Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.

  2011cites this paper
• Induced Adipocyte Cell-Sheet Ameliorates Cardiac Dysfunction in a Mouse Myocardial Infarction Model: A Novel Drug Delivery System for Heart Failure

  2011cites this paper
• The effect of vascular endothelial growth factor (VEGF) presentation within fibrin matrices on endothelial cell branching.

  2011cites this paper
• Sustained Cytoplasmic Delivery and Anti-viral Effect of PLGA Nanoparticles Carrying a Nucleic Acid-Hydrolyzing Monoclonal Antibody

  2011cites this paper
• In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing.

  2011cites this paper
• Release kinetics and in vitro bioactivity of basic fibroblast growth factor: effect of the thickness of fibrous matrices.

  2011cites this paper
• Strategies for organ level tissue engineering

  2010cites this paper
• Analytical approaches to uptake and release of hydrogel-associated FGF-2

  2010cites this paper
• FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.

  2010cites this paper
• Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A.

  2010cites this paper
• In Vitro and In Vivo Chondrogenesis of Rabbit Bone Marrow–Derived Stromal Cells in Fibrin Matrix Mixed with Growth Factor Loaded in Nanoparticles

  2009cites this paper
• Nucleus pulposus tissue engineering: a brief review

  2009cites this paper
• Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery.

  2009cites this paper
• International Journal of Nanomedicine Dovepress Controlled Release of Chitosan/heparin Nanoparticle- Delivered Vegf Enhances Regeneration of Decellularized Tissue-engineered Scaffolds

  year unknowncites this paper